Genetic therapies for RNA mis-splicing diseases
RNA mis-splicing diseases account for up to 15% of all inherited diseases, ranging from neurological to myogenic and metabolic disorders. With greatly increased genomic sequencing being performed for individual patients, the number of known mutations affecting splicing has risen to 50-60% of all dis...
Main Authors: | Hammond, S, Wood, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
Genetic therapies for RNA mis-splicing diseases.
by: Hammond, S, et al.
Published: (2011) -
RNA splicing: disease and therapy.
by: Douglas, A, et al.
Published: (2011) -
RNA-targeted splice-correction therapy for neuromuscular disease.
by: Wood, M, et al.
Published: (2010) -
IN VIVO INTERROGATION OF THE CONTRIBUTION OF SPECIFIC SPLICING FACTORS TO PATHOLOGICAL MIS-SPLICING IN HUNTINGTON´S DISEASE
by: David Lozano-Muñoz, et al.
Published: (2023-10-01) -
RNA Targeting in Inherited Neuromuscular Disorders: Novel Therapeutic Strategies to Counteract Mis-Splicing
by: Veronica Verdile, et al.
Published: (2021-10-01)